Plug Power Inc. News
Forget Green Hydrogen, Pink Hydrogen is Heating Up
Zero-carbon hydrogen can be made from nuclear power plants, too. Could it save America's aging fleet?
Cramer's Mad Money Recap 4/19: Plug Power, Bank of America, Twitter
Jim Cramer says the U.S. has advantages that short-sighted investors don't understand.
FuelCell Energy Dumps on Earnings. Here’s the One Trade Bulls Have Left
FuelCell Energy stock is falling after reporting a very disappointing quarterly result. Here's the one trade bulls may have left now.
Cramer's Mad Money Recap 12/23: Pfizer, Nvidia, Tesla
Jim Cramer's got a list of who's naughty, who's nice and which companies deserve a lump of coal.
Cramer's Mad Money Recap 12/6: Earnings, Covid and Interest Rates
Jim Cramer says investors should ignore pre-market jitters and focus on the three things the market really cares about.
Berkshire's Munger: Stocks Even Crazier Now Than in Dot.com Boom
The forward 12-month price-earnings multiple for the S&P 500 stood at 20.4 on Thursday, up from the 10-year average of 16.6.
Plug Power, Exxon Mobil Touted by Wells Fargo on Spending Bill
Wells Fargo put together a list of stocks that should benefit if the Senate joins the House in approving the Build Back Better bill.
Cramer's Mad Money Recap 11/15: Tesla, Rivian, Square
From EVs and cybersecurity to fintech, Jim Cramer hunting innovative companies this week in San Francisco and Silicon Valley.
Cramer's Mad Money Recap: Tesla, Ford, Meta, Microsoft
Investors can follow the big money managers as they buy these stocks on the dips, riding toward a happy holiday season.
Premarket Movers Monday - Harley Davidson, Plug Power, Tesla
Stocks moving in premarket trading include Tesla, Plug Power, AMC Entertainment, Harley Davidson and Novavax.
Bank of England Plans Emergency Bond Market Intervention Amid Historic Pound Slump
"Were dysfunction in this market to continue or worsen, there would be a material risk to UK financial stability," the BoE said.
Biogen Stock Soars On Promising Data From Late-Stage Alzheimer’s Drug Trial
“Today’s announcement gives patients and their families hope that lecanemab, if approved, can potentially slow the progression of Alzheimer’s disease," said Biogen CEO Michel Vounatsos.
Apple Stock Slides On Report of iPhone Production U-Turn Amid Waning Consumer Demand
Just weeks after reportedly asking suppliers to prepared for a surge in iPhone demand, Apple is reportedly paring-back plans to boost production.
DocuSign Stock Jumps On Job Cut Plan Under New CEO Allan Thygesen
DocuSign said the job cuts will "improve operating margin and support the company’s growth, scale and profitability objectives".